INHIBITION OF PHENYTOIN METABOLISM BY SULTHIAME IN EPILEPTIC PATIENTS

被引：48

作者：

HOUGHTON, GW ^{[1
]}

RICHENS, A ^{[1
]}

机构：

[1] ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1,ENGLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1974年 / 1卷 / 01期

关键词：

D O I：

10.1111/j.1365-2125.1974.tb00207.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：59 / 66

页数：8

共 15 条

[1]

ARNOLD K, 1970, CLIN PHARMACOL THER, V11, P121

[2]

ATKINSON AJ, 1973, CLIN PHARMACOL THER, V14, P521

[3] EFFECT OF DOSAGE INCREMENTS ON BLOOD PHENYTOIN CONCENTRATIONS [J].

BOCHNER, F ;

HOOPER, WD ;

TYRER, JH ;

EADIE, MJ .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1972, 35 (06) :873-876

[4]

GLAZKO AJ, 1972, ANTIEPILEPTIC DRUGS

[5] THE USE OF OSPOLOT IN THE TREATMENT OF EPILEPSY [J].

GORDON, N .

EPILEPSIA, 1964, 5 (01) :68-73

[6]

GREEN JR, 1972, ANTIEPILEPTIC DRUGS

[7] SULTHIAME (OSPOLOT) AS INHIBITOR OF DIPHENYLHYDANTOIN METABOLISM [J].

HANSEN, JM ;

KRISTENSEN, M ;

SKOVSTED, L .

EPILEPSIA, 1968, 9 (01) :17-+

[8]

HOUGHTON GW, 1973, BRIT J PHARMACOL, V49, pP157

[9]

HOUGHTON GW, IN PRESS

[10]

INGRAM T T, 1963, Dev Med Child Neurol, V5, P313

← 1 2 →